Our research at the Conference on Retroviruses and Opportunistic Infections (CROI) 2024
MRC Clinical Trials Unit at UCL researchers and our collaborators will present the latest research from our HIV trials at CROI 2024.
Common antiseptic is safe for premature newborns’ skin
NeoCHG found that whole-body application of chlorhexidine is safe for hospitalised, premature newborn babies, paving the way for larger clinical trials to test how well it prevents deaths.
New prostate cancer treatments could reach men sooner
A new study shows that better prostate cancer treatments could reach men almost two years sooner than is currently possible.
Single drug could be an alternative option for long-term management of HIV
Long-term follow-up results from the PIVOT trial confirm that protease inhibitor monotherapy preserves future drug options as well as standard combination therapy.
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Major international clinical trials answering questions of global public health significance
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes